| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 141, 1259-1264, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
T Paavonen and R Renkonen
Department of Pathology, University of Helsinki, Finland.
High endothelial venules (HEV) lined by the high endothelium are the sites where leukocytes enter into the lymph nodes from the blood. Lymphocyte homing into lymph nodes is organ-selective, i.e., different molecules are involved in the lymphocyte homing to peripheral nodes compared with mucosa associated lymphoid tissue. The traffic into peripheral nodes is regulated by the expression of L-selectin on leukocytes and its ligand on HEVs. The ligand for L-selectin is suggested to be a 50, 90, or 105 kd glycoprotein, which is sulfated, fucosylated, and sialylated. The two other members of the selectin family (E- and P-selectin) recognize sialyl-Lewis x and -Lewis a (sLex and sLea, respectively) carbohydrate motifs, and there is preliminary data suggesting that this would also be the case for L-selectin. We have initiated a study to identify the expression of these sialylated structures on endothelial surfaces. We present data that show that HEVs in peripheral nodes, but not in the mucosa-associated lymphoid tissue, express large quantities of sLex and sLea identified by MAbs in immunohistology. Endothelium in capillaries or larger vessels in non- lymphoid tissues do not react with anti-sLex or -Lea mAbs. Only 1-2% of the lymphocytes in the peripheral blood express sLex and so far only the skin-homing lymphocytes are known to be sLex positive in larger quantities. We show that in many occasions the B cells in the peripheral lymph-node germinal centers are also sLex-, but not sLea- positive, and provide evidence of the restricted pattern of sLex and sLea expression on peripheral lymph-node HEVs. We propose that they are at least parts of the ligand for L-selectin.
This article has been cited by other articles:
![]() |
S. K. Toppila-Salmi, J. P. Myller, T. V. M. Torkkeli, J. V. Muhonen, J. A. Renkonen, M. E. Rautiainen, and R. L. O. Renkonen Endothelial L-Selectin Ligands in Sinus Mucosa during Chronic Maxillary Rhinosinusitis Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1350 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huopaniemi, M. Kolmer, J. Niittymaki, M. Pelto-Huikko, and R. Renkonen Inflammation-induced transcriptional regulation of Golgi transporters required for the synthesis of sulfo sLex glycan epitopes Glycobiology, December 1, 2004; 14(12): 1285 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, J. G. Krueger, M.-C. J. Kao, E. Lee, F. Du, A. Menter, W. H. Wong, and A. M. Bowcock Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array Physiol Genomics, March 18, 2003; 13(1): 69 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Renkonen, O. Tynninen, P. Hayry, T. Paavonen, and R. Renkonen Glycosylation Might Provide Endothelial Zip Codes for Organ-Specific Leukocyte Traffic into Inflammatory Sites Am. J. Pathol., August 1, 2002; 161(2): 543 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Toppila, T. Paavonen, A. Laitinen, L. A. Laitinen, and R. Renkonen Endothelial Sulfated Sialyl Lewis x Glycans, Putative L-Selectin Ligands, Are Preferentially Expressed in Bronchial Asthma but Not in Other Chronic Inflammatory Lung Diseases Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 492 - 498. [Abstract] [Full Text] |
||||
![]() |
L. Tu, P. G. Murphy, X. Li, and T. F. Tedder L-Selectin Ligands Expressed by Human Leukocytes Are HECA-452 Antibody-Defined Carbohydrate Epitopes Preferentially Displayed by P-Selectin Glycoprotein Ligand-1 J. Immunol., November 1, 1999; 163(9): 5070 - 5078. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Rosen Endothelial Ligands for L-Selectin : From Lymphocyte Recirculation to Allograft Rejection Am. J. Pathol., October 1, 1999; 155(4): 1013 - 1020. [Full Text] [PDF] |
||||
![]() |
S. Toppila, T. Paavonen, M. S. Nieminen, P. Hayry, and R. Renkonen Endothelial L-Selectin Ligands Are Likely to Recruit Lymphocytes into Rejecting Human Heart Transplants Am. J. Pathol., October 1, 1999; 155(4): 1303 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tu, M. D. Delahunty, H. Ding, F. W. Luscinskas, and T. F. Tedder The Cutaneous Lymphocyte Antigen Is an Essential Component of the L-selectin Ligand Induced on Human Vascular Endothelial Cells J. Exp. Med., January 18, 1999; 189(2): 241 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mitsuoka, M. Sawada-Kasugai, K. Ando-Furui, M. Izawa, H. Nakanishi, S. Nakamura, H. Ishida, M. Kiso, and R. Kannagi Identification of a Major Carbohydrate Capping Group of the L-selectin Ligand on High Endothelial Venules in Human Lymph Nodes as 6-Sulfo Sialyl Lewis X J. Biol. Chem., May 1, 1998; 273(18): 11225 - 11233. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Clark, R. C. Fuhlbrigge, and T. A. Springer L-Selectin Ligands That Are O-glycoprotease Resistant and Distinct from MECA-79 Antigen are Sufficient for Tethering and Rolling of Lymphocytes on Human High Endothelial Venules J. Cell Biol., February 9, 1998; 140(3): 721 - 731. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |